Atlas Trials

Metformin Versus Vildagliptin in Reducing Risk of Metabolic Syndrome Complications Progression

Clinical trial NCT04485845 · UNKNOWN

Trial details

NCT number
NCT04485845
Sponsor
Cairo University
Status
UNKNOWN
Phase
Phase 4
Study type
INTERVENTIONAL
Metabolic SyndromeDiabete Type 2Kidney Insufficiency
Start date
2019-11-01
Primary completion
2020-08-30
Enrollment
39

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.